Apr 19, 2021 | Securities Class Action Archive
Emergent BioSolutions Investors With Losses Greater Than $100,000 Encouraged To Contact Kehoe Law Firm, P.C.
Kehoe Law Firm, P.C. is investigating potential securities claims on behalf of investors of Emergent BioSolutions Inc. (“Emergent” or the “Company”) (NYSE: EBS) to determine whether the Company engaged in securities fraud or other unlawful business practices.
On April 19, 2021, a class action lawsuit was filed in United States District Court for the District Of Maryland on behalf of Emergent investors who purchased, or otherwise acquired, Emergent’s common stock between July 6, 2020 and March 31, 2021, both dates inclusive (the “Class Period”).
INVESTORS WHO PURCHASED, OR OTHERWISE ACQUIRED, EMERGENT’S COMMON STOCK DURING THE CLASS PERIOD AND SUFFERED LOSSES GREATER THAN $100,000 ARE ENCOURAGED TO COMPLETE KEHOE LAW FIRM’S SECURITIES CLASS ACTION QUESTIONNAIRE OR CONTACT KEVIN CAULEY, DIRECTOR, CLIENT RELATIONS, (215) 792-6676, EXT. 802, [email protected], [email protected], [email protected], TO DISCUSS THE SECURITIES CLASS ACTION INVESTIGATION OR POTENTIAL LEGAL CLAIMS.
Apr 15, 2021 | Securities Class Action Archive
Kehoe Law Firm, P.C. is investigating potential securities claims on behalf of investors of Canaan Inc. (“Canaan” or the “Company”) (NASDAQ: CAN) to determine whether the Company engaged in securities fraud or other unlawful business practices.
On April 15, 2021, a class action lawsuit was filed in United States District Court, Southern District of New York, on behalf of Canaan investors who purchased, or otherwise acquired, Canaan’s American Depositary Receipts (ADRs”) between February 10, 2021 and April 9, 2021, both dates inclusive (the “Class Period”).
According to the class action complaint, statements Canaan issued during the Class Period about the Company’s business metrics and financial prospects were materially false and misleading in that they concealed that due to ongoing supply chain disruptions and the introduction of the Company’s next-generation A12 series bitcoin mining machines – which had cannibalized sales of the older product offerings – Canaan’s sales and net revenues had significantly declined.
INVESTORS WHO PURCHASED, OR OTHERWISE ACQUIRED, THE COMPANY’S ADRs DURING THE CLASS PERIOD AND SUFFERED LOSSES GREATER THAN $50,000 ARE ENCOURAGED TO COMPLETE KEHOE LAW FIRM’S SECURITIES CLASS ACTION QUESTIONNAIRE OR CONTACT KEVIN CAULEY, DIRECTOR, CLIENT RELATIONS, (215) 792-6676, EXT. 802, [email protected], [email protected], [email protected], TO DISCUSS THE SECURITIES CLASS ACTION INVESTIGATION OR POTENTIAL LEGAL CLAIMS.
Apr 12, 2021 | Securities Class Action Archive
Kehoe Law Firm, P.C. is investigating potential securities claims on behalf of investors of Champignon Brands Inc. (“Champignon” or the “Company”) (OTC: SHRMF) to determine whether the Company engaged in securities fraud or other unlawful business practices.
On April 10, 2021, a class action lawsuit was filed in United States District Court, Central District of California, on behalf of Champignon investors who purchased, or otherwise acquired, Champignon securities between March 27, 2020 and February 17, 2021, both dates inclusive (the “Class Period”).
According to the class action complaint, throughout the Class Period, the Champignon Defendants made false and/or misleading statements and/or failed to disclose that (1) Champignon had undisclosed material weaknesses and insufficient financial controls; (2) Champignon’s previously issued financial statements were false and unreliable; (3) Champignon’s earlier reported financial statements would need to be restated; (4) Champignon’s acquisitions involved an undisclosed related party; (5) as a result of the foregoing and subsequent reporting delays and issues, the British Columbia Securities Commission would suspend Champignon from trading; and (6) as a result, the Champignon Defendants’ statements about Champignon’s business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.
INVESTORS WHO PURCHASED, OR OTHERWISE ACQUIRED, THE COMPANY’S SECURITIES DURING THE CLASS PERIOD AND SUFFERED SIGNIFICANT LOSSES ARE ENCOURAGED TO COMPLETE KEHOE LAW FIRM’S SECURITIES CLASS ACTION QUESTIONNAIRE OR CONTACT KEVIN CAULEY, DIRECTOR, CLIENT RELATIONS, (215) 792-6676, EXT. 802, [email protected], [email protected], [email protected], TO DISCUSS THE SECURITIES CLASS ACTION INVESTIGATION OR POTENTIAL LEGAL CLAIMS.
Mar 26, 2021 | Consumer Protection, Employment & Technology Archive
Personal Touch Holding Corp. Notifying Current And Former Employees And Patients Of A Cybersecurity Attack Possibly Affecting Personally Identifiable Information And Protected Health Information – Kehoe Law Firm, P.C. Class Action Data Breach Investigation
Kehoe Law Firm, P.C. is investigating potential class action claims on behalf of victims of a January 27, 2021 cybersecurity attack on the private cloud hosted by Personal Touch Holding Corp.’s (“PTHC”) managed service providers.
PTHC’s recently published Notice of Security Breach stated that the following information was involved in the cyberattack:
PTHC’s private cloud-stored business records of PTHC and its direct and indirect subsidiaries . . . where patients’ personally identifiable information and protected health information were contained. This information may include medical treatment information, insurance card, and health plan benefit numbers, medical record numbers, first and last name, address, telephone numbers, date of birth, Social Security number, and financial information, including check copies, credit card numbers, and bank account information.
Employee information may include first and last name, address, telephone numbers, date of birth, Social Security numbers (including dependent and spouse Social Security numbers), driver’s license number, passport numbers, birth certificates, background and credit reports, demographic information, usernames and passwords used at the Company, personal email addresses, fingerprints, insurance card and health and welfare plan benefit numbers, retirement benefits information, medical treatment information, check copies, and other financial information necessary for payroll.
PTHC’s “Notice of Security Breach” listed the following direct and indirect company subsidiaries:
PT Intermediate Holding, Inc.; Personal-Touch Home Care of W. Va. Inc.; PT Hospice of PA Inc.; Personal Touch Care of PA, Inc.; Personal Touch Home Care of Ohio, Inc.; Personal Touch Home Care of Baltimore, Inc.; PT Home Services of San Antonio, Inc.; Houston-Personal Touch Home Care, Inc.; PT Home Services of Dallas, Inc.; Houston-Personal Touch Home-Aides, Inc.; Personal Touch Home Care of Indiana, Inc.; Personal Touch Home Care of Greater Portsmouth, Inc.; Personal-Touch Home Care of N.J., Inc.; PT Management Services, Inc.; Personal-Touch Home Care of N.Y., Inc.; Personal Touch Home Care of KY, Inc.; Personal Touch Home Care of S.E. Mass., Inc.; PTS of Westchester, Inc.; Personal-Touch Home Aides of New York, Inc.; Personal Touch Home Care of Westchester, Inc.; Personal Touch Home Care of Long Island, Inc.; Personal Touch Home-Aides, Inc. (PA); Personal Touch Home Care of VA, Inc.; Personal Touch Hospice of VA, Inc.; Personal Touch Home –Aides, Inc. (MA); Personal Touch Home Aides of VA, Inc.; Personal Touch Home Care of Mass., Inc.; Personal Touch Home Aides of Baltimore, Inc.; Personal Touch Home Care IPA, Inc.
IF YOU BELIEVE YOU ARE A VICTIM OF PTHC’S DATA BREACH AND HAVE QUESTIONS OR CONCERNS ABOUT KEHOE LAW FIRM’S CLASS ACTION DATA BREACH INVESTIGATION OR POTENTIAL LEGAL CLAIMS, PLEASE CONTACT MICHAEL YARNOFF, ESQ., (215) 792-6676, EXT. 804, [email protected], [email protected].
Mar 17, 2021 | Securities Class Action Archive
Class Action Filed On Behalf Of CytoDyn, Inc. Investors – CYDY Investors With Losses Greater Than $100,000 Encouraged To Contact Kehoe Law Firm, P.C.
Kehoe Law Firm, P.C. is investigating potential securities claims on behalf of investors of CytoDyn, Inc. (“CytoDyn” or the “Company”) (OTC: CYDY) to determine whether the Company engaged in securities fraud or other unlawful business practices.
On March 17, 2021, a class action lawsuit was filed against CytoDyn in United States District Court on behalf of CytoDyn investors who purchased, or otherwise acquired, CytoDyn common stock between March 27, 2020 and March 9, 2021, both dates inclusive (the “Class Period”).
According to the class action complaint, CytoDyn issued numerous press releases, conducted conference calls, participated in interviews, and aggressively utilized several third-party investor relations and stock newsletter services to tout Leronlimab as a potential treatment for COVID-19 and to pump up the stock price of CytoDyn while executives aggressively sold shares.
The class action complaint also alleges that in addition to overstating the viability of Leronlimab as a COVID-19 treatment, CytoDyn also engaged in a wrongful scheme with its lender, Iliad Research and Trading L.P. (“Iliad”), and its principal John Fife (“Fife”), whereby Iliad and other Fife entities operated as an unregistered securities dealer for CytoDyn. In connection with Iliad lending funds to CytoDyn, Iliad obtained a convertible promissory note from CytoDyn and converted the note into newly issued shares of CytoDyn and sold those shares into the public market at a profit, in violation of the dealer registration requirements of the federal securities laws.
INVESTORS WHO PURCHASED, OR OTHERWISE ACQUIRED, THE COMPANY’S COMMON STOCK DURING THE CLASS PERIOD AND SUFFERED LOSSES GREATER THAN $100,000 ARE ENCOURAGED TO COMPLETE KEHOE LAW FIRM’S SECURITIES CLASS ACTION QUESTIONNAIRE OR CONTACT KEVIN CAULEY, DIRECTOR, CLIENT RELATIONS, (215) 792-6676, EXT. 802, [email protected], [email protected], [email protected], TO DISCUSS THE SECURITIES CLASS ACTION INVESTIGATION OR POTENTIAL LEGAL CLAIMS.
